Clinical Trials

6 results for Bladder Cancer


Molecular Correlates of Sensitivity and Resistance to Therapy in Genitourinary Malignancy

  • Condition: Healthy Control, Localized Urothelial Carcinoma of the Renal Pelvis and Ureter, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Soft Tissues, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter, Recurrent Bl
  • Intervention: Other: Cytology Specimen Collection Procedure, Other: Laboratory Biomarker Analysis
  • Study ID: NCT01050504
View Trial

Familial and Atypical Urothelial Cancer Registry

  • Condition: Urothelial Cancer, Renal Pelvis Cancer, Ureter Cancer, Bladder Cancer
  • Intervention: Other: saliva sample and questionaire, Other: saliva sample, questionaire
  • Study ID: NCT00902590
View Trial

A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer

  • Condition: Non-muscle Invasive Bladder Cancer
  • Intervention: Biological: BCG+ALT-803, Biological: BCG
  • Study ID: NCT02138734
View Trial

Recombinant Human Interleukin-7 to Promote T-Cell Recovery After Cord Blood Transplantation

  • Condition: Leukemia, Lymphoma, Myeloma, Myeloproliferative Diseases
  • Intervention: Drug: Busulfan, Drug: Fludarabine, Drug: Clofarabine, Drug: Rabbit ATG, Radiation: Total Body Irradiation (TBI), Procedure: Cord Blood Infusions, Drug: Rituximab, Drug: Cyclophosphamide, Procedure: Natural Killer Cell Infusion, Drug: Melphalan, Drug: Mesna
  • Study ID: NCT02727803
View Trial

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer of the Bladder and Kidney

  • Condition: Urothelial Cancer, Cancer, Bladder Neoplasms, Urinary Bladder Cancer
  • Study ID: NCT00872495
View Trial

Genetic Susceptibility to Bladder Cancer: A Molecular Epidemiology Approach

  • Condition: Bladder Cancer
  • Intervention: Behavioral: Interviews
  • Study ID: NCT00848289
View Trial